Does liver-derived ANGPTL3 play a role in cardiometabolic risk? Current evidence and future perspectives

“ ...as ANGPTL3 seems to be involved in the partitioning of fatty acids and regulation of free fatty acid-induced insulin sensitivity, it appears to be an ideal target to modulate cardiovascular risk in the context of atherogenic dyslipidemia and insulin resistance... ”